Associate Professor

Shahin Lockman

Associate Professor in the Department of Immunology and Infectious Diseases

Immunology and Infectious Diseases

slockman@hsph.harvard.edu

Other Positions

Associate Professor of Medicine

Medicine

Brigham and Women's Hospital


Bibliography

Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial.

Lockman S, Brummel SS, Ziemba L, Stranix-Chibanda L, McCarthy K, Coletti A, Jean-Philippe P, Johnston B, Krotje C, Fairlie L, Hoffman RM, Sax PE, Moyo S, Chakhtoura N, Stringer JS, Masheto G, Korutaro V, Cassim H, Mmbaga BT, João E, Hanley S, Purdue L, Holmes LB, Momper JD, Shapiro RL, Thoofer NK, Rooney JF, Frenkel LM, Amico KR, Chinula L, Currier J.

Lancet. 2021 04 03. 397(10281):1276-1292. PMID: 33812487


News

Marking 15+ years of a program that saved millions

October 11, 2019 – PEPFAR—the President’s Emergency Plan for AIDS Relief—has saved millions of lives and prevented millions of HIV infections since its launch in 2003 by President George W. Bush. To mark 15+ years of the program,…

Harvard Chan researchers present new findings at AIDS conference

The 22nd International AIDS Conference drew HIV/AIDS experts from around the world, including researchers from Harvard T.H. Chan School of Public Health, who presented new findings on topics including the risks of a new AIDS drug, “test-and-treat” campaigns…